High Efficiency of Kanakinumabum for a Patient with a Late Diagnosed Chronic Infantile Neurological Cutaneous Articular Syndrome (CINCA)

High Efficiency of Kanakinumabum for a Patient with a Late Diagnosed Chronic Infantile Neurological Cutaneous Articular Syndrome (CINCA)

The article presents the monitoring of a severe course of CINCA/NOMID syndrome diagnosed at late stages. The use of monoclonal antibodies to IL 1 — kanakinumabum — in a patient with chronic neurological cutaneous and articular syndrome was successful: fever, cutaneous and pain syndromes were complet...

Full description

Bibliographic Details
Main Authors: T. V. Sleptsova, E. I. Alekseeva, K. V. Savostianov, A. A. Pushkov, T. M. Bazarova, S. I. Valieva, O. L. Lomakina, R. V. Denisova, K. B. Isaeva, E. G. Chistyakova
Format: Article
Language:English
Published: Paediatrician Publishers, LLC 2015-11-01
Series:Pediatričeskaâ Farmakologiâ
Subjects:
children
autoinflammatory syndromes
cinca
chronic infantile neurological cutaneous articular syndrome
kanakinumabun
human monoclonal antibody to 1 interleukin
Online Access:https://www.pedpharma.ru/jour/article/view/516

Similar Items

Similar Items